# Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers

> **NCT04206657** · PHASE1 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 42 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** 1mg KHK7580
- **DRUG:** 3mg KHK7580
- **DRUG:** 6mg KHK7580
- **DRUG:** 12mg KHK7580
- **DRUG:** 6mg KHK7580 for 8days

## Key facts

- **NCT ID:** NCT04206657
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-20
- **Primary completion:** 2021-06-17
- **Final completion:** 2021-06-17
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2021-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04206657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04206657, "Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT04206657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*